Breast Cancer
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Making Treatment DecisionsIt’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
Forward Look
The Chemotherapy ChoiceAdding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.
by Kris Conner
-
Survivor Profile
Changing CourseInitially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
ADCs Make Their MarkAntibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast CancerNew oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Pausing Treatment for PregnancyYoung women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
by Carolyn Bernhardt
-
Sex and Gender Minorities Face Disparities in Breast Cancer CareLesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
-
Chronic Stress and CancerAccumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
